BofA raised the firm’s price target on DocuSign (DOCU) to $102 from $85 and keeps a Neutral rating on the shares following Q2 results that the firm says “suggest that DocuSign’s recovery story is very much back on track.” However, the cycle is early and the firm believes that go to market efforts in both the direct and partner channel are “a work in progress,” adding that it also believes much of the near-term upside it sees is priced into shares at the current valuation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign price target raised to $85 from $80 at Wells Fargo
- DocuSign’s Hold Rating: Balancing Improved Billings with Growth Concerns
- DocuSign’s Strong Q2 Performance and Strategic AI Initiatives Justify Buy Rating
- DocuSign’s Optimistic Yet Cautious Outlook: Awaiting Sustained Growth for a Rating Upgrade
- DocuSign’s Market Position Stable but Valuation Concerns Persist: Analyst Maintains Hold Rating